BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces First Quarter 2026 Results

Progyny (PGNY)ProgynyEarnings

Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --

Related news

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

HSTMHealthStream2026-05-04 20:30 EST

HealthStream Announces First Quarter 2026 Results

HSTMHealthStream2026-04-21 13:25 EST

HealthStream to Host First Quarter 2026 Earnings Conference Call

FEMYFEMASYS2026-05-08 20:05 EST

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

TXMDTherapeuticsMD2026-05-12 20:05 EST

TherapeuticsMD Announces First Quarter 2026 Financial Results

SERASera Prognostics2026-04-22 12:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

COOThe Cooper Companies2026-02-05 21:15 EST

CooperCompanies Announces Release Date for First Quarter 2026

TXMDTherapeuticsMD2025-05-13 20:05 EST

TherapeuticsMD Announces First Quarter 2025 Financial Results

TDOCTeladoc2026-04-29 20:05 EST

Teladoc Health Reports First Quarter 2026 Results

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States